Gene · 3459
Papers3,929
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,929
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cobalt-mediated suppression of IFN-γ-JAK-STAT1 signaling reprograms IDO1-driven immunosuppression for metalloimmunotherapy. | Sci Adv | 2026 | 42758828 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals immune remodeling in lymph nodes of gastric adenocarcinoma. | Clin Exp Metastasis | 2026 | 42754734 | PubTator, text mining | PubMed |
| Spatial and functional specialization of human splenic innate lymphoid cells. | Nat Commun | 2026 | 42711319 | PubTator, text mining | PubMed |
| Mycobacterial infections and recurrent osteomyelitis in a patient with an autosomal dominant mutation in IFN-gamma receptor 1 with overexpression of the receptor. | Int J Infect Dis | 2026 | 42702282 | PubTator, text mining | PubMed |
| Reduction of CXCR3+CCR6+ CD4+ T Cells and IL-17+ RORγt+ CD4+ T Cells During Secukinumab Treatment Identifies Patients With Axial Spondyloarthritis Responsive to Subsequent Biologic Therapy. | ACR Open Rheumatol | 2026 | 42666100 | PubTator, text mining | PubMed |
| Deciphering HPV-Associated Immune Evasion in Cervical Cancer Through Multi-Omics Profiling and Computational Screening. | Anal Cell Pathol (Amst) | 2026 | 42635083 | PubTator, text mining | PubMed |
| mi-RNA-mRNA Alterations in Sorted T-Cells of Acquired Aplastic Anemia: Validating the Observations of a Pilot Study. | Int J Lab Hematol | 2026 | 42604788 | PubTator, text mining | PubMed |
| Immune exhaustion in esophageal cancer: interferon pathway dysregulation and neoadjuvant therapy response. | Front Cell Dev Biol | 2026 | 42597607 | PubTator, text mining | PubMed |
| KRASG12D inhibition reprograms the tumor-induced immunosuppressive environment and enhances NK cell-mediated antitumor immunity. | Sci Adv | 2026 | 42490421 | PubTator, text mining | PubMed |
| Triple IFN pathway deficiency sensitizes mice to human respiratory virus infection independent of human viral receptor expression. | Nat Commun | 2026 | 42463654 | PubTator, text mining | PubMed |
| Plasma proteomics based on machine learning predict the early risk of kidney outcomes in patients with DKD: a prospective cohort study from UK Biobank. | Front Nephrol | 2026 | 42445298 | PubTator, text mining | PubMed |
| CAR T Cells Targeting O-Glycosylated Fibronectin Exhibit Potent Cytolytic Activity and Combine with Tumoral Toll-Like Receptor Agonism to Overcome Tumor Resistance. | Cancer Immunol Res | 2026 | 42397032 | PubTator, text mining | PubMed |
| Genetic determinants of childhood onset systemic lupus erythematosus. | Lupus Sci Med | 2026 | 42336467 | PubTator, text mining | PubMed |
| BAP1 loss impairs IFN-γ signaling and enhances NK cell-mediated cytotoxicity in myeloid leukemia. | Cancer Immunol Immunother | 2026 | 42295372 | PubTator, text mining | PubMed |
| Simultaneous TCR and IL-2 agonism selectively enhances epitope-specific CD8 T-cell responses during chronic viral infection. | J Virol | 2026 | 42294879 | PubTator, text mining | PubMed |
| Pathogenic signatures and therapeutic evaluation of emergent MPXV Clade Ib in low-susceptibility and immunocompromised mouse models. | BMC Microbiol | 2026 | 42260341 | PubTator, text mining | PubMed |
| Translational Opportunity of Engineered IFNγ-eEVs Through Targeted Inhibition of JAK/STAT1 Signaling, Mimicking IVIg Therapy. | bioRxiv | 2026 | 42232505 | PubTator, text mining | PubMed |
| Systematic analysis of programmed cell death-related genes in sepsis reveals immune heterogeneity and enables patient stratification. | Front Cell Dev Biol | 2026 | 42232056 | PubTator, text mining | PubMed |
| Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration. | Cancer Cell | 2026 | 42208540 | PubTator, text mining | PubMed |
| Mendelian susceptibility to mycobacterial disease: Clinical, immunological, and genetic study in India. | J Hum Immun | 2026 | 42170591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3459/papers